The SUCCEED Trial: Maintenance Ridaforolimus for Metastatic Soft- Tissue Sarcomas - a podcast by American Society of Clinical Oncology (ASCO)

from 2013-05-30T02:59:14

:: ::

This podcast provides observations and commentary on the JCO article,"Results of an international randomized phase 3 trial of the mTOR inhibitor, ridaforolimus, versus placebo to control metastatic sarcomas in patients following benefit from prior chemotherapy" by authors George Demetri, et al.